Clinical Trial Update: Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for advanced non-small cell lung cancer evaluating pemetrexed and carboplatin with or without sorafenib. The study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Alimta (pemetrexed)
• CARBOPLATIN (Carboplatin)
• Nexavar (Sorafenib)

Snippet

Sponsor: University Hospital Muenster | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: TERMINATED